In contrast, almost 70% of breast cancers express ER and PR and require their ligands during breast cancer progression, suggesting that these cells switch from paracrine to autocrine mechanisms, as they acquire the ability to proliferate during the tumorigenic process. The gene discussed is PGR; the disease is breast carcinoma.